- Home
- Protocols and Guidelines
- Current CAP Guidelines
- HER2 Testing in Breast Cancer - 2023 Guideline Update
- Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy
- Diagnostic Testing for Diffuse Gliomas
- Laboratory Detection and Initial Diagnosis of Monoclonal Gammopathies
- Validating Whole Slide Imaging for Diagnostic Purposes in Pathology - Update
- Laboratory Workup of Lymphoma in Adults
- Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies
- Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer – Update
- Quantitative Image Analysis of HER2 IHC for Breast Cancer
- Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors – Update
- Human Papillomavirus Testing in Head and Neck Carcinomas
- Effective Communication of Urgent Diagnoses and Significant Unexpected Diagnoses in Surgical Pathology and Cytopathology - Reaffirmation
- Initial Diagnostic Workup of Acute Leukemia
- Molecular Biomarkers for the Evaluation of Colorectal Carcinoma
- HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma
- Bone Marrow Synoptic Reporting for Hematologic Neoplasms
- Interpretive Diagnostic Error Reduction
- Uniform Labeling of Blocks and Slides in Surgical Pathology
- Principles of Analytic Validation of Immunohistochemical Assays
- The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions
External Guidelines Endorsed by the CAP
The following guidelines produced by other organizations have been evaluated by the Center Guideline Committee and officially endorsed by the CAP.
American Society of Clinical Oncology Molecular and Cellular Diagnostics in Localized Prostate Cancer
Date endorsed: August 14, 2020
- Read the editorial discussing the role of the pathologist in the molecular and cellular diagnosis of prostate cancer.